Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolanda Alvarez

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept studyJagtar Singh Nijjar, Katharine Abbott-Banner, Yolanda Alvarez, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2015
Prevalence of antibiotic use: a comparison across various European health care data sourcesRuth Brauer, Ana Ruigómez, Gerry Downey, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fracturesPatrick C Souverein, Victoria Abbing-Karahagopian, Elisa Martin, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2015
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU ProjectConsuelo Huerta, Victoria Abbing-Karahagopian, Gema Requena, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2024
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectionJose Javier Fernández, Arturo Marín, Romel Rosales, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept studyJagtar Singh Nijjar, Katharine Abbott-Banner, Yolanda Alvarez, et al.
Pharmacoepidemiology and Drug Safety|July 9, 2015
Prevalence of antibiotic use: a comparison across various European health care data sourcesRuth Brauer, Ana Ruigómez, Gerry Downey, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fracturesPatrick C Souverein, Victoria Abbing-Karahagopian, Elisa Martin, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2015
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU ProjectConsuelo Huerta, Victoria Abbing-Karahagopian, Gema Requena, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2024
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectionJose Javier Fernández, Arturo Marín, Romel Rosales, et al.
Pageof 8